18-janv.-2012
Bayer MaterialScience commissions new hydrogenation technical center
EUR 5 million investment in Chempark Dormagen - Pooling of research activities for the efficient production of MDI and TDI
Dormagen, January 2012 – Bayer MaterialScience has commissioned a new technical
center for the development of isocyanate production processes at Chempark Dormagen. The research
center was erected in just under a year with an investment of EUR 5 million.
“All global research activities related to the production of aromatic isocyanates have now been pooled in the new hydrogenation technical center,” said Dr. Joachim Wolff, head of the polyurethanes business and member of the Executive Committee of Bayer MaterialScience, on the occasion of the commissioning. “The associated efficiency gains in the research and optimization of the production processes will help to further expand our global technological leadership.”
The state-of-the-art facility is focused on hydrogenation technology for the production of precursors to diphenylmethane diisocyanate (MDI) and toluene diisocyanate (TDI). MDI is the starting product for rigid polyurethane foam, which enables particularly efficient insulation of buildings, in particular. Over its service life, it saves as much as 70 times more energy than is needed to produce the foam. TDI is used to make flexible polyurethane foam for comfortable upholstered furniture and mattresses.
MDI is based on benzene, which is first nitrated into nitrobenzene and then hydrogenated to produce aniline. An additional step then converts the aniline to diphenylmethane diamine, the direct precursor to MDI. A catalyst is used to produce aniline from nitrobenzene and hydrogen gas. With the conventional isothermic process, which is performed at a constant temperature, the substantial heat generated during the reaction must be dissipated using heat transfer oils. The reaction takes place inside a reactor block, in which many thousands of tubes containing the catalyst have been welded together. Finally, the aniline must be painstakingly purified of byproducts before it can be used further.
The adiabatic variant developed by Bayer MaterialScience is a current example of innovative process development in the area of hydrogenation. The technology eliminates the need for heat transfer and enables a substantial gain in efficiency. Here the reaction takes place in a large steel vessel, in which the catalyst is placed on a grating. The heat of reaction is dissipated together with the gas flow, eliminating the need for the circulating oil loop. In addition, the product is also of significantly higher purity. “The technology is already proving to be extremely successful in our world-scale facility in Shanghai, China, with an annual production capacity of 350,000 metric tons. The conventional process would have been too complex and too expensive for a facility of this size,” said Dr. Thorsten Dreier, who heads the isocyanate research department at polyurethane production.
The researchers plan to concentrate on the further optimization of both process variants at the new technical center. Other focal points will be researching and improving the hydrogenation of dinitrotoluene to obtain toluene diamine, the direct precursor to TDI, and also the Deacon process for the oxidation of hydrogen chloride.
It is not just the efficiency of the production processes that plays a central role at the new technical center. The building itself is state-of-the-art and was designed for sustainability using innovative materials from the EcoCommercial Building network.
About Bayer MaterialScience:
With 2010 sales of EUR 10.2 billion, Bayer MaterialScience is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. At the end of 2010, Bayer MaterialScience had 30 production sites and employed approximately 14,700 people around the globe. Bayer MaterialScience is a Bayer Group company.
This news release is available for download from the Bayer MaterialScience press server at www.press.bayerbms.com.
Find more information at www.materialscience.bayer.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Bayer MaterialScience commissions new hydrogenation technical center
EUR 5 million investment in Chempark Dormagen - Pooling of research activities for the efficient production of MDI and TDI
“All global research activities related to the production of aromatic isocyanates have now been pooled in the new hydrogenation technical center,” said Dr. Joachim Wolff, head of the polyurethanes business and member of the Executive Committee of Bayer MaterialScience, on the occasion of the commissioning. “The associated efficiency gains in the research and optimization of the production processes will help to further expand our global technological leadership.”
The state-of-the-art facility is focused on hydrogenation technology for the production of precursors to diphenylmethane diisocyanate (MDI) and toluene diisocyanate (TDI). MDI is the starting product for rigid polyurethane foam, which enables particularly efficient insulation of buildings, in particular. Over its service life, it saves as much as 70 times more energy than is needed to produce the foam. TDI is used to make flexible polyurethane foam for comfortable upholstered furniture and mattresses.
MDI is based on benzene, which is first nitrated into nitrobenzene and then hydrogenated to produce aniline. An additional step then converts the aniline to diphenylmethane diamine, the direct precursor to MDI. A catalyst is used to produce aniline from nitrobenzene and hydrogen gas. With the conventional isothermic process, which is performed at a constant temperature, the substantial heat generated during the reaction must be dissipated using heat transfer oils. The reaction takes place inside a reactor block, in which many thousands of tubes containing the catalyst have been welded together. Finally, the aniline must be painstakingly purified of byproducts before it can be used further.
The adiabatic variant developed by Bayer MaterialScience is a current example of innovative process development in the area of hydrogenation. The technology eliminates the need for heat transfer and enables a substantial gain in efficiency. Here the reaction takes place in a large steel vessel, in which the catalyst is placed on a grating. The heat of reaction is dissipated together with the gas flow, eliminating the need for the circulating oil loop. In addition, the product is also of significantly higher purity. “The technology is already proving to be extremely successful in our world-scale facility in Shanghai, China, with an annual production capacity of 350,000 metric tons. The conventional process would have been too complex and too expensive for a facility of this size,” said Dr. Thorsten Dreier, who heads the isocyanate research department at polyurethane production.
The researchers plan to concentrate on the further optimization of both process variants at the new technical center. Other focal points will be researching and improving the hydrogenation of dinitrotoluene to obtain toluene diamine, the direct precursor to TDI, and also the Deacon process for the oxidation of hydrogen chloride.
It is not just the efficiency of the production processes that plays a central role at the new technical center. The building itself is state-of-the-art and was designed for sustainability using innovative materials from the EcoCommercial Building network.
About Bayer MaterialScience:
With 2010 sales of EUR 10.2 billion, Bayer MaterialScience is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. At the end of 2010, Bayer MaterialScience had 30 production sites and employed approximately 14,700 people around the globe. Bayer MaterialScience is a Bayer Group company.
This news release is available for download from the Bayer MaterialScience press server at www.press.bayerbms.com.
Find more information at www.materialscience.bayer.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Responsible Care